Tag: subcutaneous immunoglobulin (scig) market insights

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Subcutaneous Immunoglobulin (SCIG) Market from 2024 to 2033?
The subcutaneous immunoglobulin market has experienced rapid growth, anticipated to grow from $11.19 billion in 2023 to $12.72 billion in 2024 at a CAGR of 13.7%. Factors contributing to this growth include the rising prevalence of immunodeficiency disorders, patient preference for home care, and improved reimbursement policies.

The subcutaneous immunoglobulin market is projected to grow to $21.38 billion by 2028 at a CAGR of 13.9%. Growth is attributed to the increasing prevalence of neurological disorders, acceptance of immunoglobulin therapy, and expanding healthcare facilities. Trends include advancements in drug delivery systems and developments in antibody therapy.

Claim Your Free Sample of the Global Subcutaneous Immunoglobulin (SCIG) Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp

What Key Factors Are Fueling the Growth of the Subcutaneous Immunoglobulin (SCIG) Market?
The prevalence of secondary immunodeficiency diseases is expected to drive the growth of the subcutaneous immunoglobulin market. These conditions arise from compromised immune systems due to factors like aging and immunosuppressive treatments. Subcutaneous immunoglobulin therapy helps strengthen weakened immune systems, especially in chronic conditions. The UK Health Security Agency reported in October 2023 that there were 3,805 new HIV diagnoses in England in 2022, a 22% rise from the previous year. Thus, the increase in secondary immunodeficiency diseases is driving the subcutaneous immunoglobulin market.

What Are the Major Segments of the Subcutaneous Immunoglobulin (SCIG) Market?
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses

What New Trends Are Transforming the Subcutaneous Immunoglobulin (SCIG) Market?
Companies are focusing on unique formulations like subcutaneous human-klhw to bolster immune system treatments. For instance, in March 2022, Grifols S.A. launched XEMBIFY 20% subcutaneous immunoglobulin, aimed at treating primary immunodeficiency. This ready-to-use formulation simplifies treatment and is stable at room temperature for up to 24 months.

Order Now for Fast Delivery of Your Subcutaneous Immunoglobulin (SCIG) Market Report!
https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Which Regions Are Driving Growth in the Subcutaneous Immunoglobulin (SCIG) Market?
North America was the largest region in the subcutaneous immunoglobulin  market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the subcutaneous immunoglobulin (scig) market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Subcutaneous Immunoglobulin (SCIG) Market Include

1. Subcutaneous Immunoglobulin (SCIG) Market Executive Summary
2. Subcutaneous Immunoglobulin (SCIG) Market Segments
3. Subcutaneous Immunoglobulin (SCIG) Market Size And Template Market Growth Rate
4.  Key Subcutaneous Immunoglobulin (SCIG) Market Trends
5. Major Subcutaneous Immunoglobulin (SCIG) Market Drivers
……
25. Key Mergers And Acquisitions In The Subcutaneous Immunoglobulin (SCIG) Market
26. Top Subcutaneous Immunoglobulin (SCIG) Companies
27. Subcutaneous Immunoglobulin (SCIG) Market Opportunities And Strategies
28. Subcutaneous Immunoglobulin (SCIG) Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Immunoglobulins Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Intravenous Immunoglobulin Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Current Market Overview

• The subcutaneous immunoglobulin market is expanding swiftly.
• 2023 Market Size: $11.19 billion.
• 2024 Market Size: Expected to reach $12.72 billion, with a CAGR of 13.7%.
• Growth Drivers:
  • Increased prevalence of immunodeficiency disorders.
  • Rise in patient preference for home-based care.
  • Enhanced therapeutic efficacy.
  • Growth in awareness and diagnosis rates.
  • Favorable reimbursement policies.

Future Market Projections

• The market will continue to grow significantly.
• 2028 Market Size: Expected to reach $21.38 billion, with a CAGR of 13.9%.
• Growth Drivers:
  • Growing prevalence of neurological disorders.
  • Increasing prevalence of autoimmune diseases.
  • Rising awareness and acceptance of immunoglobulin therapy.
  • Expanding applications in neurology and dermatology.
  • Expansion of healthcare facilities.
• Major Trends:
  • Advancements in drug delivery systems.
  • Increasing demand for home infusion therapies.
  • Developments in antibody therapy.
  • Innovations in formulations and SCIG.

View More On The Subcutaneous Immunoglobulin (SCIG) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Impact of Secondary Immunodeficiency Diseases

Growing Prevalence and Market Impact

• Secondary Immunodeficiency Diseases: Conditions caused by external factors like aging, immunosuppressive treatments, and environmental toxins.
• Impact: These diseases necessitate subcutaneous immunoglobulin therapy, which strengthens the immune system and prevents infections.
• Example:
  • UK Health Security Agency Report (October 2023): 3,805 new HIV diagnoses in England in 2022, a 22% rise from the previous year.
• Conclusion: Increased prevalence of secondary immunodeficiency diseases drives market growth.

Rising Neurological Disorders

Contribution to Market Expansion

• Neurological Disorders: Includes conditions like Alzheimer’s, ALS, brain tumors, etc.
• Increasing Factors: Aging populations, environmental toxins, genetic predispositions, lifestyle changes.
• Therapeutic Benefits:
  • Modulates immune response.
  • Reduces inflammation.
  • Stabilizes neuromuscular junctions.
  • Slows disease progression and improves symptoms.
• Example:
  • Alzheimer’s Association Report (March 2022): 6.5 million Americans aged 65 and older living with Alzheimer’s dementia, projected to reach 13.8 million by 2060.
• Conclusion: Rising neurological disorders contribute to market growth.

Major Players in the Subcutaneous Immunoglobulin Market

Key Companies

• Major Companies:
  • Pfizer Inc.
  • Johnson & Johnson.
  • Prothena Corporation plc.
  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Company Limited.
  • Amgen Inc.
  • Baxter International Inc.
  • CSL Behring.
  • Lonza Group.
  • Grifols S.A.
  • Octapharma AG.
  • Dr. Reddy’s Laboratories.
  • Intas Pharmaceutical Ltd.
  • Emergent BioSolutions Inc.
  • Bharat Serums and Vaccines Limited (BSV).
  • Kamada Pharmaceuticals.
  • CinnaGen Co.
  • Shire plc.

Advancements in SCIG Therapy for Primary Immunodeficiency Diseases

Innovative Products and Treatments

• Subcutaneous Human-klhw: A unique formulation for treating primary immunodeficiency diseases.
• Example:
  • Grifols S.A. (March 2022): Launched XEMBIFY 20% SCIG, designed for primary immunodeficiency.
  • Features:
    • Ready-to-use formulation.
    • Simplifies treatment process.
    • Increases patient convenience.
    • Stable at room temperature for up to 24 months.

Market Segmentation

Product Types and Applications

• By Product Type:
  • Immunoglobulin A (IgA).
  • Immunoglobulin G (IgG).
  • Immunoglobulin M (IgM).
• By Application:
  • Primary Immunodeficiency Disorders.
  • Autoimmune Diseases.
  • Neurological Disorders.
  • Other Applications.
• By End-Use:
  • Clinics.
  • Hospitals.
  • Homecare.
  • Other End-Uses.

Regional Insights

Geographic Market Dynamics

• Largest Region (2023): North America.
• Fastest-Growing Region (Forecast Period): Asia-Pacific.

The subcutaneous immunoglobulin market is set for continued growth, driven by increasing prevalence of various disorders and advancements in therapy and drug delivery systems.

Request A Sample Of The Global Subcutaneous Immunoglobulin (SCIG) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15935&type=smp